Healthcare provider profile · identity verified

Kimberly Small, NP

Nurse Practitioner · MASHPEE, MA · NPI 1578629028

Profile state: partd only Open Payments: 2025 Medicare Part D: 2024 Last identity check: 2026-08-10 Page data build: 2026-08-12

Verified facts

What the public records show

We did not find matching Open Payments records for this doctor in 2025.

These records do not establish that a payment influenced prescribing or medical care.

Payment overview · 2025

General Payments

We did not find matching Open Payments records for this doctor in the selected program year.

Separate record types

Research & Ownership

Research Payments (direct recipient): not present in the loaded data

Associated Research Funding (for example, named PI): not present in the loaded data

Ownership / Investment: not present in the loaded data

These categories are never added into the General Payments headline. Associated research funding must not be described as money the doctor personally received unless the source record supports that conclusion.

Analysis 1 · Payment-linked products

Products named in Open Payments records

No payment-linked product analysis is available because no matching General Payment records were found for the selected year.

Public prescribing for products named in payments

There is no explicit payment-product set available for a Part D comparison.

The presence of the same drug in both datasets does not show that a payment caused or influenced a prescription.

Analysis 2 · Same-company prescribing overlap

Drugs reported in other payments from the same company that also appear in Medicare Part D

This analysis is independent from products named on this doctor’s individual payment records. A row appears only when the exact Open Payments reporting entity paid this doctor, that same reporting entity reported the drug or biological on at least 10 loaded General Payment records involving at least 2 distinct recipient NPIs, and this doctor has the same non-generic brand in public Part D data. This does not mean the company owns or manufactures the drug.

There is no payer-company set available for this comparison.

These facts do not show that a payment was for the drug, that the company owns or manufactures the drug, or that a payment caused or influenced prescribing.

Public Medicare Part D data

Provider-and-drug rows loaded for 2024

Brand	Generic	Claims	Beneficiaries
Levothyroxine Sodium	Levothyroxine Sodium	222	74
Atorvastatin Calcium	Atorvastatin Calcium	193	74
Omeprazole	Omeprazole	165	53
Lisinopril	Lisinopril	161	62
Losartan Potassium	Losartan Potassium	160	55
Gabapentin	Gabapentin	136	40
Rosuvastatin Calcium	Rosuvastatin Calcium	106	41
Amlodipine Besylate	Amlodipine Besylate	105	43
Tramadol Hcl	Tramadol Hcl	93	26
Lorazepam	Lorazepam	90	41
Ozempic	Semaglutide	89	16
Hydrochlorothiazide	Hydrochlorothiazide	88	32
Metoprolol Succinate	Metoprolol Succinate	82	29
Albuterol Sulfate Hfa	Albuterol Sulfate	80	26
Metformin Hcl	Metformin Hcl	77	32
Synthroid	Levothyroxine Sodium	72	17
Simvastatin	Simvastatin	71	24
Escitalopram Oxalate	Escitalopram Oxalate	66	24
Zolpidem Tartrate	Zolpidem Tartrate	56	21
Allopurinol	Allopurinol	53	14
Alprazolam	Alprazolam	51	16
Duloxetine Hcl	Duloxetine Hcl	50	15
Cefuroxime	Cefuroxime Axetil	42	39
Trazodone Hcl	Trazodone Hcl	41	16
Pantoprazole Sodium	Pantoprazole Sodium	40	18
Furosemide	Furosemide	39	suppressed
Nystatin	Nystatin	38	16
Sertraline Hcl	Sertraline Hcl	38	13
Atenolol	Atenolol	37	14
Alendronate Sodium	Alendronate Sodium	36	16
Citalopram Hbr	Citalopram Hydrobromide	36	12
Metformin Hcl Er	Metformin Hcl	36	15
Eliquis	Apixaban	35	suppressed
Metoprolol Tartrate	Metoprolol Tartrate	35	suppressed
Montelukast Sodium	Montelukast Sodium	35	11
Potassium Chloride	Potassium Chloride	34	suppressed
Famotidine	Famotidine	33	15
Fluticasone Propionate	Fluticasone Propionate	31	19
Ipratropium Bromide	Ipratropium Bromide	30	11
Methylprednisolone	Methylprednisolone	30	27
Oxycodone Hcl	Oxycodone Hcl	30	12
Valsartan	Valsartan	30	11
Pravastatin Sodium	Pravastatin Sodium	29	12
Bupropion Xl	Bupropion Hcl	28	13
Celecoxib	Celecoxib	28	suppressed
Valacyclovir	Valacyclovir Hcl	27	11
Prednisone	Prednisone	26	18
Tamsulosin Hcl	Tamsulosin Hcl	25	12
Hydrocodone-Acetaminophen	Hydrocodone/Acetaminophen	24	suppressed
Clonazepam	Clonazepam	23	suppressed
Cyclobenzaprine Hcl	Cyclobenzaprine Hcl	23	suppressed
Azithromycin	Azithromycin	21	21
Triamterene-Hydrochlorothiazid	Triamterene/Hydrochlorothiazid	21	suppressed
Mirtazapine	Mirtazapine	20	suppressed
Ropinirole Hcl	Ropinirole Hcl	20	suppressed
Amoxicillin-Clavulanate Potass	Amoxicillin/Potassium Clav	19	18
Esomeprazole Magnesium	Esomeprazole Magnesium	19	suppressed
Fluconazole	Fluconazole	19	suppressed
Venlafaxine Hcl Er	Venlafaxine Hcl	19	suppressed
Ezetimibe	Ezetimibe	18	suppressed
Myrbetriq	Mirabegron	18	suppressed
Arnuity Ellipta	Fluticasone Furoate	17	suppressed
Fluticasone-Salmeterol	Fluticasone Propion/Salmeterol	17	suppressed
Wixela Inhub	Fluticasone Propion/Salmeterol	17	suppressed
Hydrocortisone	Hydrocortisone	16	13
Sulfamethoxazole-Trimethoprim	Sulfamethoxazole/Trimethoprim	16	14
Trulicity	Dulaglutide	16	suppressed
Advair Hfa	Fluticasone Propion/Salmeterol	15	suppressed
Buspirone Hcl	Buspirone Hcl	15	suppressed
Carvedilol	Carvedilol	15	suppressed
Clopidogrel	Clopidogrel Bisulfate	15	suppressed
Fenofibrate	Fenofibrate	15	suppressed
Oxycodone-Acetaminophen	Oxycodone Hcl/Acetaminophen	15	suppressed
Jardiance	Empagliflozin	14	suppressed
Mounjaro	Tirzepatide	14	suppressed
Olmesartan Medoxomil	Olmesartan Medoxomil	14	suppressed
Amitriptyline Hcl	Amitriptyline Hcl	13	suppressed
Bupropion Hcl	Bupropion Hcl	13	suppressed
Cephalexin	Cephalexin	13	suppressed
Hydralazine Hcl	Hydralazine Hcl	13	suppressed
Clindamycin Hcl	Clindamycin Hcl	12	suppressed
Losartan-Hydrochlorothiazide	Losartan/Hydrochlorothiazide	12	suppressed
Nitrofurantoin Mono-Macro	Nitrofurantoin Monohyd/M-Cryst	12	suppressed
Paroxetine Hcl	Paroxetine Hcl	12	suppressed
Felodipine Er	Felodipine	11	suppressed
Rybelsus	Semaglutide	11	suppressed
Warfarin Sodium	Warfarin Sodium	11	suppressed

Timeline

Payment and prescribing data by year

Open Payments and Medicare Part D may refer to different years. They are shown separately rather than aligned as if they describe the same period.

Year	General Payments	Main payer	Explicit products	Company overlaps	Part D coverage
2025	—	—	—	—	—
2024	—	—	—	—	Complete

Questions to ask

Questions you could discuss with your doctor

Are there reasonable alternatives I should understand when we discuss treatment options?
How should I interpret the industry-payment records shown here in the context of my care?

These are general questions generated from reviewed templates. They are not personalized medical advice.

Sources and limitations

How to read this page

Payment and Medicare prescribing data can cover different years; every comparison shows both years explicitly.
Part D does not represent a doctor’s entire practice; it excludes many patients and is subject to CMS public-release thresholds.
Company–drug relationships must have an auditable source, a precise relationship type, and a valid evidence period. Unresolved mappings are not published.
Generic drug claims are not attributed to a specific manufacturer without manufacturer-level evidence.
When a source extract is incomplete, missing rows are never treated as proof of no payments or no prescriptions.

Loaded source releases

Dataset	Year	Publication	Source
CMS Open Payments — General Payments	2025	2026-06-30	Original source
Medicare Part D Prescribers by Provider and Drug	2024	2026-05-06	Original source
NPPES Data Dissemination V2	current / reference data	2026-08-10	Original source

Methodology version: 2.1

Editorial template version: 2.4

Product contract version: 2.0

Schema version: 0.7.0

Page data build: 2026-08-12T23:34:59.370714+00:00

Publication policy: eligible for indexing after public-launch controls are enabled

Full methodology · Questions & answers · Report a possible error